Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Pediatr Hematol Oncol ; 44(2): e450-e452, 2022 Mar 01.
Article in English | MEDLINE | ID: covidwho-2063086

ABSTRACT

In people with sickle cell disease (SCD), oral abscesses are concerning clinical conditions and carry a high risk of postoperative sickle cell complications. We present an unusual case of a 14-year-old girl with SCD whose initial presentation of facial swelling, headaches, jaw pain, and paresthesia mimicked an odontogenic abscess. She was diagnosed with vaso-occlusive crisis in the mandibular bone and successfully managed noninvasively. This is among the youngest cases of paresthesia in the lower lip in SCD, which provided a clue that postponing invasive aspiration or biopsy was possible under empiric antibiotics and close observation.


Subject(s)
Anemia, Sickle Cell , Jaw Diseases , Abscess/diagnosis , Abscess/etiology , Adolescent , Anemia, Sickle Cell/complications , Female , Humans , Mandible , Pain/diagnosis , Pain/etiology , Paresthesia/complications
2.
Public Health Rep ; 137(2): 234-238, 2022.
Article in English | MEDLINE | ID: covidwho-1643029

ABSTRACT

Sickle cell disease (SCD) is associated with increased risk of poor health outcomes from respiratory infections, including COVID-19 illness. We used US death data to investigate changes in SCD-related mortality before and during the COVID-19 pandemic. We estimated annual age- and quarter-adjusted SCD-related mortality rates for 2014-2020. We estimated the number of excess deaths in 2020 compared with 2019 using the standardized mortality ratio (SMR). We found 1023 SCD-related deaths reported in the United States during 2020, of which 86 (8.4%) were associated with COVID-19. SCD-related deaths, both associated and not associated with COVID-19, occurred most frequently among adults aged 25-59 years. The SCD-related mortality rate changed <5% year to year from 2014 to 2019 but increased 12% in 2020; the sharpest increase was among adults aged ≥60 years. The SMR comparing 2020 with 2019 was 1.12 (95% CI, 1.06-1.19). Overall, 113 (95% CI, 54-166) excess SCD-related deaths occurred in 2020.


Subject(s)
Anemia, Sickle Cell/mortality , COVID-19/epidemiology , Adolescent , Adult , Age Distribution , Anemia, Sickle Cell/complications , COVID-19/complications , Child , Child, Preschool , Ethnicity , Humans , Infant , Middle Aged , Mortality/trends , Race Factors , SARS-CoV-2 , Time Factors , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL